{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T11:54:35Z","timestamp":1793361275375,"version":"4.5.0"},"reference-count":24,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2020,4,20]],"date-time":"2020-04-20T00:00:00Z","timestamp":1587340800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>To investigate criteria for treatment response and remission in patients with axial SpA as assessed by whole-body magnetic resonance imaging (WB-MRI) of axial and peripheral joints and entheses during treatment with golimumab.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We performed an investigator-initiated cohort study of 53 patients who underwent WB-MRI at weeks 0, 4, 16 and 52 after initiation of golimumab. Images were assessed according to the Spondyloarthritis Research Consortium of Canada MRI SI joint inflammation index, Canada\u2013Denmark MRI spine inflammation score and the MRI peripheral joints and entheses inflammation index.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>At weeks 4, 16 and 52, WB-MRI demonstrated an at least 50% reduction of MRI inflammation of the sacroiliac joints in 16, 29 and 32 (30%, 55% and 60%) patients, of the spine in 20, 30 and 31 (38%, 57% and 58%) patients and of peripheral joints and entheses in 8, 17 and 15 (15%, 32% and 28%) patients, respectively. The BASDAI50 response was achieved by 29, 31 and 31 (55%, 58% and 58%) patients, while ASDAS clinically important improvement (ASDAS-CII) was achieved by 37, 40 and 34 (70%, 75% and 64%) patients. WB-MRI remission criteria for spine, sacroiliac joints and peripheral joints and entheses were explored; total WB-MRI remission was attained by 2, 6 and 3 (4%, 11% and 6%) patients. At week 16, among 35 patients with an at least 50% reduction in the MRI Axial Inflammation Index (sacroiliac joint and spine inflammation), 29 (83%) achieved BASDAI50 and 35 (100%) achieved ASDAS-CII; among 16 patients with MRI axial inflammation non-response, 14 (88%) were BASDAI50 non-responders and 11 (69%) did not achieve ASDAS-CII.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>WB-MRI demonstrated a significant reduction of inflammation in both the spine, sacroiliac joints and peripheral joints and entheses during golimumab treatment. Few patients achieved total WB-MRI remission. Combining spinal and sacroiliac joint inflammation in an MRI Axial Inflammation Index increased the ability to capture response.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Trial registration<\/jats:title>\n                  <jats:p>ClinicalTrials.gov, http:\/\/clinicaltrials.gov, NCT02011386.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keaa153","type":"journal-article","created":{"date-parts":[[2020,3,13]],"date-time":"2020-03-13T20:23:50Z","timestamp":1584131030000},"page":"3358-3368","source":"Crossref","is-referenced-by-count":21,"title":["Novel whole-body magnetic resonance imaging response and remission criteria document diminished inflammation during golimumab treatment in axial spondyloarthritis"],"prefix":"10.1093","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2877-1582","authenticated-orcid":false,"given":"Simon","family":"Krabbe","sequence":"first","affiliation":[{"name":"Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Rigshospitalet, Glostrup, Denmark"},{"name":"Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris","family":"Eshed","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Imaging, Sheba Medical Center, Affiliated to the Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inge J","family":"S\u00f8rensen","sequence":"additional","affiliation":[{"name":"Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Rigshospitalet, Glostrup, Denmark"},{"name":"Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakob","family":"M\u00f8ller","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark"},{"name":"Department of Radiology, Herlev and Gentofte Hospital, Herlev, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bente","family":"Jensen","sequence":"additional","affiliation":[{"name":"Center for Rheumatology and Spine Diseases, Frederiksberg Hospital, Frederiksberg, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ole R","family":"Madsen","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark"},{"name":"Center for Rheumatology and Spine Diseases, Herlev and Gentofte Hospital, Hellerup, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mette","family":"Klarlund","sequence":"additional","affiliation":[{"name":"Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Rigshospitalet, Glostrup, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne J","family":"Pedersen","sequence":"additional","affiliation":[{"name":"Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Rigshospitalet, Glostrup, Denmark"},{"name":"Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark"},{"name":"Center for Rheumatology and Spine Diseases, Herlev and Gentofte Hospital, Hellerup, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikkel","family":"\u00d8stergaard","sequence":"additional","affiliation":[{"name":"Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Rigshospitalet, Glostrup, Denmark"},{"name":"Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,4,20]]},"reference":[{"key":"2020102707111470200_keaa153-B1","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1056\/NEJMra1406182","article-title":"Ankylosing spondylitis and axial spondyloarthritis","volume":"374","author":"Taurog","year":"2016","journal-title":"N Engl J Med"},{"key":"2020102707111470200_keaa153-B2","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1136\/annrheumdis-2013-204055","article-title":"Evolution of radiographic damage in ankylosing spondylitis: a 12-year prospective follow-up of the OASIS study","volume":"74","author":"Ramiro","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"2020102707111470200_keaa153-B3","first-page":"ii1","article-title":"The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis","volume":"68(Suppl II","author":"Sieper","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"2020102707111470200_keaa153-B4","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1136\/annrheumdis-2016-210770","article-title":"2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis","volume":"76","author":"van der Heijde","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"2020102707111470200_keaa153-B5","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.1002\/art.23969","article-title":"Efficacy and safety of golimumab in patients with ankylosing spondylitis: results of a randomized, double-blind, placebo-controlled, phase III trial","volume":"58","author":"Inman","year":"2008","journal-title":"Arthritis Rheum"},{"key":"2020102707111470200_keaa153-B6","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1002\/art.39257","article-title":"A randomized, double-blind, placebo-controlled, sixteen-week study of subcutaneous golimumab in patients with active nonradiographic axial spondyloarthritis","volume":"67","author":"Sieper","year":"2015","journal-title":"Arthritis Rheum"},{"key":"2020102707111470200_keaa153-B7","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1056\/NEJMoa1505066","article-title":"Secukinumab, an interleukin-17A inhibitor, in ankylosing spondylitis","volume":"373","author":"Baeten","year":"2015","journal-title":"N Engl J Med"},{"key":"2020102707111470200_keaa153-B8","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1136\/annrheumdis-2017-211734","article-title":"Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force","volume":"77","author":"Smolen","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"2020102707111470200_keaa153-B9","doi-asserted-by":"crossref","first-page":"621","DOI":"10.3899\/jrheum.170408","article-title":"Whole-body magnetic resonance imaging in axial spondyloarthritis: reduction of sacroiliac, spinal, and entheseal inflammation in a placebo-controlled trial of adalimumab","volume":"45","author":"Krabbe","year":"2018","journal-title":"J Rheumatol"},{"key":"2020102707111470200_keaa153-B10","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1136\/ard.2010.139667","article-title":"Effects of etanercept versus sulfasalazine in early axial spondyloarthritis on active inflammatory lesions as detected by whole-body MRI (ESTHER): a 48-week randomized controlled trial","volume":"70","author":"Song","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"2020102707111470200_keaa153-B11","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3899\/jrheum.181159","article-title":"Whole-body magnetic resonance imaging inflammation in peripheral joints and entheses in axial spondyloarthritis: distribution and changes during adalimumab treatment","volume":"47","author":"Krabbe","year":"2020","journal-title":"J Rheumatol"},{"key":"2020102707111470200_keaa153-B12","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1007\/s00330-013-2794-1","article-title":"Assessment of therapeutic response in ankylosing spondylitis patients undergoing anti-tumour necrosis factor therapy by whole-body magnetic resonance imaging","volume":"23","author":"Karpitschka","year":"2013","journal-title":"Eur Radiol"},{"key":"2020102707111470200_keaa153-B13","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1136\/annrheumdis-2013-204537","article-title":"A treat-to-target strategy with methotrexate and intra-articular triamcinolone with or without adalimumab effectively reduces MRI synovitis, osteitis and tenosynovitis and halts structural damage progression in early rheumatoid arthritis: results from the OPERA randomized controlled trial","volume":"74","author":"Axelsen","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"2020102707111470200_keaa153-B14","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1093\/rheumatology\/ket425","article-title":"Whole-body MRI assessment of disease activity and structural damage in rheumatoid arthritis: first step towards an MRI joint count","volume":"53","author":"Axelsen","year":"2014","journal-title":"Rheumatology"},{"key":"2020102707111470200_keaa153-B15","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1093\/rheumatology\/keu439","article-title":"Head-to-toe whole-body MRI in psoriatic arthritis, axial spondyloarthritis and healthy subjects: first steps towards global inflammation and damage scores of peripheral and axial joints","volume":"54","author":"Poggenborg","year":"2015","journal-title":"Rheumatology"},{"key":"2020102707111470200_keaa153-B16","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1136\/annrheumdis-2013-204239","article-title":"Enthesitis in patients with psoriatic arthritis, axial spondyloarthritis and healthy subjects assessed by \u2018head-to-toe\u2019 whole-body MRI and clinical examination","volume":"74","author":"Poggenborg","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"2020102707111470200_keaa153-B17","doi-asserted-by":"crossref","first-page":"i93","DOI":"10.1136\/annrheumdis-2011-200798","article-title":"How to define remission in ankylosing spondylitis","volume":"71(Suppl II","author":"Sieper","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"2020102707111470200_keaa153-B18","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1136\/ard.2009.108233","article-title":"The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection","volume":"68","author":"Rudwaleit","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"2020102707111470200_keaa153-B19","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/art.21445","article-title":"Spondyloarthritis Research Consortium of Canada magnetic resonance imaging index for assessment of sacroiliac joint inflammation in ankylosing spondylitis","volume":"53","author":"Maksymowych","year":"2005","journal-title":"Arthritis Rheum"},{"key":"2020102707111470200_keaa153-B20","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3899\/jrheum.140519","article-title":"Development and preliminary validation of the Spondyloarthritis Research Consortium of Canada magnetic resonance imaging sacroiliac joint structural score","volume":"42","author":"Maksymowych","year":"2015","journal-title":"J Rheumatol"},{"key":"2020102707111470200_keaa153-B21","doi-asserted-by":"crossref","first-page":"e001057","DOI":"10.1136\/rmdopen-2019-001057","article-title":"The Canada\u2013Denmark MRI scoring system of the spine in patients with axial spondyloarthritis: updated definitions and scoring rules and inter-reader reliability in a multiple reader setting","volume":"5","author":"Krabbe","year":"2019","journal-title":"RMD Open"},{"key":"2020102707111470200_keaa153-B22","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1002\/art.21337","article-title":"Spondyloarthritis Research Consortium of Canada magnetic resonance imaging index for assessment of spinal inflammation in ankylosing spondylitis","volume":"53","author":"Maksymowych","year":"2005","journal-title":"Arthritis Rheum"},{"key":"2020102707111470200_keaa153-B23","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.3899\/jrheum.161114","article-title":"Whole-body magnetic resonance imaging in inflammatory arthritis: systematic literature review and first steps towards standardization and an OMERACT scoring system","volume":"44","author":"\u00d8stergaard","year":"2017","journal-title":"J Rheumatol"},{"key":"2020102707111470200_keaa153-B24","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.3899\/jrheum.181084","article-title":"Development and validation of an OMERACT MRI whole-body score for inflammation in peripheral joints and entheses in inflammatory arthritis (MRI-WIPE)","volume":"46","author":"Krabbe","year":"2019","journal-title":"J Rheumatol"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/59\/11\/3358\/34038280\/keaa153.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/59\/11\/3358\/34038280\/keaa153.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,27]],"date-time":"2020-10-27T11:56:09Z","timestamp":1603799769000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/59\/11\/3358\/5822740"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,20]]},"references-count":24,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2020,4,20]]},"published-print":{"date-parts":[[2020,11,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keaa153","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,11]]},"published":{"date-parts":[[2020,4,20]]}}}